Impact of post-COVID symptoms on activity and participation of women and men.

Impact of post-COVID symptoms on activity and participation of women and men.

Publication date: Oct 17, 2024

Post-COVID syndrome is affecting many organ systems and arises as a major public health problem with millions of cases worldwide. The primary aim of this study is the analysis of health problems, activity limitations and participation restrictions (ALPR) of participants with post-COVID symptoms and the investigation of correlations between these elements to derive statements about the rehabilitation need, also depending on sex. A retrospective cohort study was performed to collect longitudinal data from January 2022 to January 2023 using the Covid-19 Rehabilitation Needs Questionnaire (RehabNeQ). Patients completed the questionnaire at the Department of Rehabilitation- and Sports Medicine at Hannover Medical School. The 1st assessment included 307 study participants, of whom 54 showed up for the 2nd, 7 for the 3rd and one for the 4th assessment. Study participants with post-COVID symptoms also experience ALPR. The results show no significant difference in symptom intensity in women and men, but in intensity of ALPR. We found many correlations of varying degrees between various factors with ALPR. We found frequent correlations between fatigue and several ALPR. While these correlations apply to both sexes, we also found different correlations in women and men, indicating the different rehabilitation need of women and men.

Open Access PDF

Concepts Keywords
Covid Activity
Hannover Alpr
Rehabneq Assessment
Women Correlations
Worldwide Covid
Found
January
Men
Participants
Participation
Post
Questionnaire
Rehabilitation
Symptoms
Women

Semantics

Type Source Name
disease MESH syndrome
disease MESH Covid-19
disease IDO symptom
disease MESH infection
disease MESH dyspnea
disease MESH joint pain
disease MESH chest pain
disease MESH Cognitive impairment
disease MESH brain fog
disease MESH asthma
pathway KEGG Asthma
disease IDO intervention
drug DRUGBANK Coenzyme M
disease MESH general health
disease MESH anxiety
disease MESH Marital status
disease MESH ‘hair loss
disease MESH Visual impairment
disease MESH Tinnitus
disease MESH ‘tachycardia
disease MESH functional status
disease MESH lifestyle
drug DRUGBANK Factor IX Complex (Human)
disease IDO quality
disease MESH symptom exacerbation
disease MESH depression
disease IDO role
drug DRUGBANK Methionine
disease MESH re infection
disease MESH long COVID
disease MESH complications
drug DRUGBANK Diethylstilbestrol
drug DRUGBANK Etoperidone
pathway REACTOME Reproduction

Original Article

(Visited 3 times, 1 visits today)